Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.65 |
| ▸ | CCR2 | P41597 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | XBP1 | P17861 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29404012 | 1.00 | ESR1 (0.65) | ESR1ESR2CCR2TDP1TP53 | |
| SCHEMBL29459501 | 1.00 | ESR1 (0.65) | ESR1ESR2CCR2TDP1TP53 | |
| SCHEMBL21538491 | 0.88 | ESR1 (0.69) | ESR1ESR2TDP1MEN1KMT2A | |
| SCHEMBL296770 | 0.84 | ESR1 (0.63) | ESR1ESR2CCR2MEN1KMT2A | |
| SCHEMBL296382 | 0.84 | ESR1 (0.63) | ESR1ESR2MEN1KMT2APOLB | |
| SCHEMBL30295754 | 0.84 | ESR1 (0.63) | ESR1ESR2MEN1KMT2APOLB | |
| SCHEMBL7909628 | 0.84 | ESR1 (0.63) | ESR1ESR2CCR2MEN1KMT2A | |
| SCHEMBL22829552 | 0.83 | ESR1 (0.54) | ESR1ESR2LMNANPSR1ACHE | |
| SCHEMBL298066 | 0.83 | ESR1 (0.61) | ESR1ESR2CCR2ACHE | |
| SCHEMBL24411211 | 0.82 | ESR1 (0.45) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 792 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12215189-B2 | Bisphenol composition and polycarbonate resin | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-02-04 | — | — | US | claimed |
| US-11936103-B2 | Conductive film for antennas, and antenna | TEIJIN LIMITED (JP) | 2024-03-19 | — | — | US | claimed |
| US-20230006341-A1 | CONDUCTIVE FILM FOR ANTENNAS, AND ANTENNA | TEIJIN LIMITED (JP) | 2023-01-05 | — | — | US | claimed |
| EP-4052904-A1 | CONDUCTIVE FILM FOR ANTENNAS, AND ANTENNA | Teijin Limited (JP) | 2022-09-07 | — | — | EP | claimed |
| EP-3939957-A1 | BISPHENOL COMPOSITION AND POLYCARBONATE RESIN | Mitsubishi Chemical Corporation (JP) | 2022-01-19 | — | — | EP | claimed |
| US-20210403641-A1 | BISPHENOL COMPOSITION AND POLYCARBONATE RESIN | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-12-30 | — | — | US | claimed |
| EP-1763560-A1 | POLYARYLATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2007-03-21 | — | — | EP | claimed |
| US-7109274-B2 | Polyarylate compositions | GENERAL ELECTRIC COMPANY (US) | 2006-09-19 | — | — | US | claimed |
| WO-2006012161-A1 | POLYARYLATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-02-02 | — | — | WO | claimed |
| US-20060004152-A1 | Polyarylate compositions | GENERAL ELECTRIC COMPANY | 2006-01-05 | — | — | US | claimed |
| EP-1560871-A1 | METHOD FOR MAKING COPOLYCARBONATES | GENERAL ELECTRIC COMPANY (US) | 2005-08-10 | — | — | EP | claimed |
| WO-2004041907-A1 | METHOD FOR MAKING COPOLYCARBONATES | GENERAL ELECTRIC COMPANY (US) | 2004-05-21 | — | — | WO | claimed |
| US-6657038-B1 | Melt condensation copolymerization of dihydroxyaromatic compounds and diphenyl carbonate derivative in presence of metal hydroxide and quaternary phosphonium salt | GENERAL ELECTRIC COMPANY | 2003-12-02 | — | — | US | claimed |
| US-6576739-B2 | Conversion of the hindered bisphenol to the corresponding bischloroformate and subsequent treatment with an amine catalyst and an aqueous base to effect polymerization by hydrolysis and condenstation of bischloroformate groups | GENERAL ELECTRIC COMPANY | 2003-06-10 | — | — | US | claimed |
| US-20020111456-A1 | Method of polycarbonate preparation | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2002-08-15 | — | — | US | claimed |
| WO-2001085825-A2 | METHOD OF POLYCARBONATE PREPARATION | GENERAL ELECTRIC COMPANY (US) | 2001-11-15 | — | — | WO | claimed |
| JP-7246661-A | — | — | None | — | — | JP | disclosed |
| US-20260146124-A1 | RESIN COMPOSITION AND USES OF THE SAME | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2026-05-28 | — | — | US | disclosed |
| US-5041521-A | High impact strength, stress releiving, noncracking | BAYER AKTIENGESELLSCHAFT (DE) | 1991-08-20 | — | — | US | disclosed |
| EP-0419926-A1 | Thermoplastic alloys with polyesters and polyestercarbonates based on substituted cycloalkylidenebisphenols | BAYER AG (DE) | 1991-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215189-B2 | Bisphenol composition and polycarbonate resin | SUZ12, RB1, RRP12 | ESR1 71/4885ESR2 36/4885CCR2 1645/4885 |
| US-20260146124-A1 | RESIN COMPOSITION AND USES OF THE SAME | ARCN1, ASH2L, ITGA1 | ESR1 201/4885ESR2 188/4885CCR2 1491/4885 |
| US-20210403641-A1 | BISPHENOL COMPOSITION AND POLYCARBONATE RESIN | SUZ12, RB1, RRP12 | ESR1 71/4885ESR2 36/4885CCR2 1645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.